Lake Street Starts Kazia Therapeutics (KZIA) at Buy

Lake Street initiates coverage on Kazia Therapeutics (NASDAQ: KZIA) with a Buy rating and a price target of $32.00.

For an analyst ratings summary and ratings history on Kazia Therapeutics click here. For more ratings news on Kazia Therapeutics click here.

Shares of Kazia Therapeutics closed at $11.50 yesterday.

You May Also Be Interested In

• lululemon athletica (LULU) call put ratio 1 call to 1 put into quarter results
• Mexico imposes countervailing duties on steel imports from China and Vietnam
• Planet Labs (PL) call put ratio 2.1 calls to 1 put into quarter results